|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/52 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3484477 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17828498.0 |
| Date of filing the European patent application | 2017-07-13 | |
| (97) | Date of publication of the European application | 2019-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/042011 |
| Date | 2017-07-13 |
| (87) | Number | WO 2018/013862 |
| Date | 2018-01-18 |
| (30) | Number | Date | Country code |
| 201662362369 P | 2016-07-14 | US |
| (72) |
NIESMAN, Michael , US
ZHANG, Kai , US
|
| (73) |
Mingsight Pharmaceuticals, Inc. ,
P.O. Box 261208, San Diego, CA 92196,
US
|
| (54) | TREATMENT OF CANCER |
| TREATMENT OF CANCER |